| Literature DB >> 32326113 |
Kishor Mazumder1,2, Biswajit Biswas1, Iqbal Mahmud Raja1, Koichi Fukase3.
Abstract
Cancer or uncontrolled cell proliferation is a major health issue worldwide and is the second leading cause of deaths globally. The high mortality rate and toxicity associated with cancer chemotherapy or radiation therapy have encouraged the investigation of complementary and alternative treatment methods, such as plant-based drugs. Moreover, over 60% of the anti-cancer drugs are molecules derived from plants or their synthetic derivatives. Therefore, in the present review, an attempt has been made to summarize the cytotoxic plants available in the Indian subcontinent along with a description of their bio-active components. The review covers 99 plants of 57 families as well as over 110 isolated bioactive cytotoxic compounds, amongst which at least 20 are new compounds. Among the reported phytoconstituents, artemisinin, lupeol, curcumin, and quercetin are under clinical trials, while brazilin, catechin, ursolic acid, β-sitosterol, and myricetin are under pharmacokinetic development. However, for the remaining compounds, there is little or no information available. Therefore, further investigations are warranted on these subcontinent medicinal plants as an important source of novel cytotoxic agents.Entities:
Keywords: Indian subcontinent plants; anticancer; bioactive compounds; cytotoxic
Year: 2020 PMID: 32326113 PMCID: PMC7221707 DOI: 10.3390/molecules25081904
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Reported cytotoxic family of plants as well as their effectiveness against particular cell lines with quantification and isolated bioactive components.
| Family | Genus and Species | Parts Used | Study Methods | Cell Line | IC50 (μg/mL) | Bioactive Compounds | IC50 (μg/mL) for Bioactive Compound | Mechanism of Cytotoxicity | Reference |
|---|---|---|---|---|---|---|---|---|---|
|
|
| Leaves | In vivo DAL induced ascitic tumor model in mice | DLA, A-549 and Vero | - | - | - | Upsurge in ascitic fluid | [ |
|
|
| Leaves | MTT assay | A431 and C6 rat glioma | - | - | - | Interaction with caspases 3 and 9 topoisomerase I and p21WAF1 cell-cycle regulator | [ |
|
|
| Aerial parts, Flowers | MTT assay | MCF-7 and Hep-2 | - | - | - | - | [ |
|
|
| Leaves | MTT assay | HeLa and Vero | 293 for HeLa | - | - | - | [ |
|
| Barks, Leaves | MTT assay | AGS, HT-29, MCF-7 and MDA-MB-231 | 90, 520, 270 and 160, respectively | 2-Palmitoylglycerol, myricadiol, pyrogallol, isovanillin etc. | - | Apoptosis and DNA fragmentation | [ | |
|
|
| Leaves | MTT assay | EACC, MDA and SKBR3 | 335, 248 and 202, respectively | - | - | - | [ |
|
| Flowers | MTT assay | MCF-7 and Vero | 6.9 and 75, respectively | Eupafolin, apigenin, rhamnetin etc. | - | - | [ | |
|
|
| Flowers | MTT assay | HL-60, SMMC-7721, A-549, MCF-7 and SW480, NIH3T3 and HeLa | 35.3 and >100 for NIH3T3 and HeLa, respectively | Ervachinine, cononitarine, conofoline, conophylline and cisplatin | Ranging between 0.17 to 1.49 for conophylline | - | [ |
|
|
| Aerial Parts | MTT assay | MCF-7 and | 329.2 | Kaempferide, eriodictyol 7- | - | Interaction with caspases 3 and 8 | [ |
|
|
| Roots | HeLa, A-431, A-549, PC-3, HCT-116 and THP-1 | Ranging between 3 to 24 |
|
|
| [ | |
|
| Roots | MTT assay | MCF-7, HT-29, H5-6 and N2A | - | - | - | - | [ | |
|
|
| Whole Plant | MTT assay | HepG2 | 10.5 | - | - | Increased | [ |
|
|
| Whole Plant | MTT assay | HepG2 and HeLa | - | Gliricidin-7- | About 507 | - | [ |
|
|
| Aerial Parts | MTT assay | 148B, MG63, D-17, OSCA2, OSCA16 and OSCA50 | 167 and 178 for 148B and MG63, respectively | Dihydro- | Ranging between 8.7 to 43.6 | - | [ |
|
| Whole Plant | MTT and Comet assays | HeLa and KB | 88.6 and 372.4, respectively | - | - | - | [ | |
|
| Aerial Parts | MTT assay | Vero and HeLa | - | - | - | - | [ | |
|
| Aerial Parts | MTT assay | Vero and HeLa | - | - | - | - | [ | |
|
| Aerial Parts | MCF-7, T47D, CACO-2, HRT18, A375.S2 and WM1361A | 75.7, 79.8 and 138.5 for WM1361A, T47D and MCF-7 | Campesterol | - | Inhibition of fibroblast growth factor-mediated cell proliferation | [ | ||
|
| Flowers | MTT assay | MCF-7 and Hep-2 | 15.78 for MCF-7 | - | - | - | [ | |
|
| Leaves | MTT and SRB assays | DU-145, THP-1, MCF-7 and K562 | - | - | - | - | [ | |
|
| Aerial Parts | MTT assay | MCF-7 and Hep-2 | 93.3 and 97, respectively | - | - | - | [ | |
|
| Aerial Parts | MTT assay | Vero and HeLa | 987 and 195, respectively |
|
|
| [ | |
|
| Leaves | MTT and Clonogenic assays | DL, MCF-7 and HeLa | 27, 24 and 18, respectively | - | - | - | [ | |
|
|
| Roots, Stem | MTT assay | MCF-7, DWD, Hop62 and A2780 | 71 and 220 for MCF-7 and DWD | - | - | - | [ |
|
|
| Leaves, Flowers | MTT assay | A549 and HepG2 | - | Rutin, luteolin, diosmetin, skytanthine, etc. | - | - | [ |
|
|
| Leaves | MTT, DCFH-DA and DAPI staining assays | PC3 | 74.5 | - | - | apoptosis, nuclear condensation and ROS production | [ |
|
|
| Whole Plant | WST-1 assay | A375, MCF-7 and PC-3 | 1, 40.5 and 6, respectively | 1,3-di- | Ranging between 3 to 41 | - | [ |
|
|
| Heartwood, Leaves | MTT assay | MCF-7 and A-549 | - | Brazilin A | - | Reduction of | [ |
|
| Leaves | MTT assay | AGS | 20 | - | - | - | [ | |
|
|
| Leaves | MTT assay | VERO, NIH3T3, AGS, HT-29, MCF-7 and MDA-MB-231 | 980 and 340 for AGS and MCF-7, respectively | Apigenin, luteolin, jaceosidin, gnaphalin, etc. | - | - | [ |
|
|
| Stem Bark | DL, MCF-7 and HeLa | 25.8, 41.6 and 76.8, respectively | - | - | Reduction in glutathione level | [ | |
|
| Leaves | MTT assay | MCF-7 and MDA-MB-231 | 340 and 540, respectively | - | - | - | [ | |
|
|
| Aerial Parts | MTT assay | MCF-7 and Hep-2 | - | - | - | - | [ |
|
|
| Leaves, Fruits | MTT assay | MCF-7, HepG2 and MDA-MB-231 | 7, 64.4 and 33, respectively | - | - | - | [ |
|
|
| Aerial Parts | MTT assay | MCF-7, T47D, CACO-2, HRT-18, A375.S2 and WM1361A | - | - | - | - | [ |
|
|
| Leaves | MTT and Clonogenic assays | DL, MCF-7 and HeLa | 29.7 for DL | - | - | - | [ |
|
| Leaves, Stem | MiaPaCa-2 | - | - | - | - | [ | ||
|
|
| Stem Bark | DAL | - | - | - | - | [ | |
|
| Aerial Parts | MTT assay | MCF-7, Hep-2 and Vero | 28, 48.8 and 41.9, respectively | - | - | - | [ | |
|
| Aerial Parts | MTT assay | MCF-7, Hep-2 and Vero | 66, 75.3 and 79.5, respectively | - | - | - | [ | |
|
|
| Leaves | MTT and SRB assays | Hep-2, A549, SK-OV-3, SK-MEL-2, XF-489 and HCT-15 | - | Maysin | Ranging between 32 to 62 | - | [ |
|
|
| Aerial Parts | MTT assay | HeLa and Vero | 507 and 367, respectively | - | - | - | [ |
|
|
| Aerial Parts | MTT assay | MCF-7 and Hep-2 | 85.5 for MCF-7 | - | - | - | [ |
|
|
| Flowers | MTT assay | MCF-7 and Hep-2 | - | - | - | - | [ |
|
| Aerial Parts | MTT assay | HeLa and Vero | 980 and >1000, respectively | - | - | - | [ | |
|
| Leaves, Stem | MTT assay | RAW264.7, Caco-2 and MCF-7 | 9, 36.1 and 48.9, respectively | - | - | - | [ | |
|
| Leaves, Stem | “Alamar Blue” resazurin reduction assays | MCF-7, B16F10 and HeLa | Ranging between 14 – 36 | α-Humulene and | For MCF-7, 81 and 114, respectively | - | [ | |
|
| Leaves | DMBA-induced hamster and S-180 induced mice | - | - | - | Regulation of humoral immunity and stimulation of cell mediated immunity | [ | ||
|
| Aerial Parts | MTT assay | HeLa and Vero | >1000 | - | - | - | [ | |
|
| Aerial Parts | MTT assay | Vero and HeLa | > 1000 | - | - | - | [ | |
|
| Aerial Parts | MTT assay | MCF-7, Hep-2, T47D, CACO-2, HRT18, A375.S2 and WM1361A | - | - | - | - | [ | |
|
| Aerial Parts | MTT assay | HeLa and Vero | 513 and 593, respectively | - | - | - | [ | |
|
|
| Aerial Parts | MTT assay | HepG2 and MCF-7 | 14.5 and 25.1, respectively | Ursolic acid, β-sitosterol and lupeol | - | Interaction with caspases 3 and 9, topoisomerase I, | [ |
|
| Aerial Parts | MTT assay | HepG2 and MCF-7 | 14.4 and 11.1, respectively | Ursolic acid, β-sitosterol and lupeol | - | Interaction with caspases 3 and 9, topoisomerase I, | [ | |
|
| Aerial Parts | MTT assay | HepG2 and MCF-7 | 27.6 and 24.1, respectively | Ursolic acid, β-sitosterol and lupeol | - | Interaction with caspases 3 and 9, topoisomerase I, | [ | |
|
|
| Leaves, Seeds | MTT assay | HT-29, A-549, MCF-7, HepG-2, MDBK, EAC, HL60, SK-BR-3, AZ521, SW-480, and SMMC7721 | Ranging between 83.5 to 212.2 | Nimonol, 3′-(3-hydroxy-3-methyl-butyl)naringenin, 4′- | Ranging between 4.2 to 100 | - | [ |
|
|
| Aerial Parts | MTT assay | MCF-7 | 39.1 | Coclaurine, haiderine, lirioresinol etc. | - | Interactions with Aurora kinase, c-Kit, FGF, | [ |
|
|
| Seeds | SRB assay and MTT assays | HEK293, A549, HeLa, MCF-7, B16 and T47D | 35.3 for A549 | Noratocarpin, cudraflavone, artocarpin, brosimone, kuwanon, albanin, etc. | Ranging between 7 to 32 | Inhibition of melanin biosynthesis | [ |
|
| Roots | MTT assay | AGS, SW-872, HL-60 and HepG2 | - | - | Interaction with Fas, Fas-L, | [ | ||
|
| Fruits, Leaves | “Alamar Blue” resazurin reduction assays | MCF-7, B16F10 and HeLa | 440, 880 and >1000, respectively | - | - | - | [ | |
|
| Fruits | SRB assay | MCF-7, DLA, HL-60, HepG2, NCI-H23 and HEK-293T | 80, 175, 276.9 and 363 for MCF-7, DLA, HL-60 and HepG2, respectively | - | - | - | [ | |
|
| Leaves | MTT assay | OVCAR-8, SF-295, HCT-116 and HeLa | - | - | - | - | [ | |
|
|
| Barks | MTT assay | KB, K-562, HCT-116 and MCF-7 | 75 for KB | 38 Essential oils | Ranging between 2.11 – 78.15 | Apoptosis through | [ |
|
|
| Seeds | MTS cell proliferation assay | A2780, MCF-7, PC3 and H460 | 49, 110, 140 and 165, respectively | Pelargonidin-3- | - | - | [ |
|
|
| Aerial Parts, Roots, Stem | MTT assay | HeLa, Raji, A549, HCT 116, Vero MCF-7 and Hep-2 | - | Rotenoids and mirabilis antiviral protein (MAP) | For MAP, 150, 175, 200 against HCT116, MCF-7 and A549, respectively | - | [ |
|
|
| Flowers, Leaves | MTT assay | MCF-7 and HEP-2 | 7 for MCF-7 | - | - | - | [ |
|
| Leaves | MTT assay | MCF-7, B16F10, HeLa and Vero | 43, 170, 440 and >1000, respectively | Interaction with | [ | |||
|
| Fruits | MTT assay | MCF-7 and HeLa | - | - | - | - | [ | |
|
|
| Fruits, Leaves | MTT assay | MCF-7 | 154.9 and 668 for fruits and leaves | Nonanal, tricosane, squalene, malonic acid, etc. | - | - | [ |
|
|
| Fruits, Leaves | MTT assay | HT-29, HL-60 and SMMC-7721 | 35 for HT-29 | Trihydroxy- | 85.56 and 165.82 for HL-60 and SMMC-7721, respectively | - | [ |
|
|
| Shoots | Resazurin reduction assays | A-549 and DLD-1 | 29 and 85, respectively | Myricetin, isorhamnetin and | - | - | [ |
|
|
| Rhizomes | XTT and SRB assays | Hep3B, MDA-MB-43 and PC-3 | 32.6, 19 and 63.9, respectively | Curcubitacin | - | Apoptosis | [ |
|
|
| Woods | SRB assay | MIA-PA-CA-2, PC3, A-2780 and Molt-4 | 74, 77, 63 and 15, respectively | - | - | Interaction with caspase 3,8 and 9 proteins | [ |
|
|
| Fruits | Colo-205, DLA and EAC | 18 for Colo-205 | Piperine | - | Apoptosis | [ | |
|
| Leaves | MTT assay | UACC-62, 786–0, MCF-7, NCI-H460, OVCAR-3, PC-3, HT-29 and K-562 | - | Eupomatenoid-5 | - | - | [ | |
|
|
| Aerial Parts, Roots | MTT assay | A-549, CACO, HCT-116, HeLa, HepG2, MCF-7 and PC3 | Ranging between 9 to 27.2 | - | - | - | [ |
|
|
| Whole Plant | MTT assay | HepG2 | 9.6 | Catechin, kaempferol, mequilianin, etc. | - | Increased | [ |
|
|
| Fruits | MTT assay | VERO, NIH3T3, AGS HT-29, MCF-7 and MDA-MB-231 | 150, 97, 0.5, 998, 91 and 461, respectively | Aegicoroside A, sakurasosaponin, fusarine, fusamine etc. | - | - | [ |
|
|
| Seeds | MTT assay | MCF7, HT29, N2A, H5-6 and VCREMS | 41.9, 41.1 and 14.5 for N2A, H5-6 and VCREMS, respectively | Astragalin, paeonoside, petiolaroside, etc. | - | - | [ |
|
|
| Leaves, Flowers | MTT assay | HeLa and Vero | 576 for HeLa | - | - | - | [ |
|
| Flowers, Seeds | MTT assay | MCF-7, Hep-2, HeLa and Vero | 265 for HeLa | Nerol, geraniol, β-citronellol, linalool, nonadecane and phenylethyl alcohol | - | - | [ | |
|
|
| Barks, Woods | MTT assay | VERO, NIH3T3, AGS HT-29, MCF-7 and MDA-MB-231 | 230, 70, 90, 160, 80 and 440, respectively | - | - | DNA fragmentation and apoptosis | [ |
|
| Leaves | MTT assay | K562 | 114.4 | - | - | Apoptosis | [ | |
|
|
| Flowers | MTT assay | Hep-2, A549, H1299 and MCF-7 | 12.05, 10.53 and 28.16 for A549, H1299 and MCF-7 | - | - | - | [ |
|
|
| Flowers | MTT assay | MCF-7, HT-29 and HL-60 | 12.5 | Lupanes, oleananes, ursanes, manilkoraside, etc. | For manilkoraside, 64 and 24 against HT-29 and HL-60, respectively | DNA fragmentation | [ |
|
|
| Roots | MTT assay | MCF-7, HT-29 and HepG2 | 91.2 | Aristolactram, dihydroguaiatric acid, sauchinone, saucerneol D, manassantin A and B, saucerneol F etc. | Ranging between 10-16 | Inhibition of DNA topoisomerase I and II | [ |
|
|
| Aerial Parts, Flowers | MTT assay | MCF-7 and Hep-2 | Sinaiticin, hydrocarpin and flavonolignans | For hydrocarpin and sinaiticin, 1.2 and 7.7 against P-388 | - | [ | |
|
|
| Fruits | MTT and Clonogenic assays | DL, MCF-7 and HeLa | 27.4, 71.2 and 62.5, respectively | - | - | - | [ |
|
| Fruits | MTT and Clonogenic assays | HeLa, Vero, HepG2 and CT26 | 265, 6.9, 56.4 and 77.6, respectively | - | - | - | [ | |
|
| Fruits, Roots and Leaves | Presto Blue cell viability assay | HeLa, MCF-7 and RD | Ranging between 0.7 to 6.7 | Myricetin, quercetin, gallic acid, etc. | - | - | [ | |
|
| Roots | SRB assay | PC3, A-549, A-2780 and K-562 | 52, 46, 79 and 41, respectively | - | - | - | [ | |
|
|
| Whole Plant | MTT assay | HeLa-B75, HL-60, HEP-3B and PN-15 | - | Cucurbitacin B and isocucurbitacin B | - | - | [ |
|
|
| Leaves | HCT116, DLA and EAC | 4, 72 and 79, respectively | Benzaldehyde, pinene, octanol, germacrene, hexadecanal, etc. | - | - | [ | |
|
|
| Leaves | MTT assay | VERO, NIH3T3, AGS, HT-29, MCF-7 and MDA-MB-231 | 50 and 880 for MCF-7 and HT-29 | - | - | Apoptosis | [ |
|
| Roots | DLA induced ascites tumor model in mice | DLA | - | - | - | Apoptosis through interaction with | [ | |
|
|
| Leaves | MTT assay | DU-145 and PC-3 | 529.4 and 677.1, respectively | - | - | - | [ |
|
| Stem | “Alamar Blue” resazurin reduction assays | MCF-7, B16F10 and HeLa | 62, 137 and 336, respectively | Quercetin 3- | - | Apoptosis | [ | |
|
|
| Rhizomes | MTT assay | Hep-2 | - | Curcumin, β-sesquiphellandrene | - | Apoptosis | [ |
|
| Rhizomes | DLA, EAC, A549, SK-OV-3, SK-MEL-2, PC-3M and HCT15 | - | Gingerol | < 50 | - | [ |
Figure 1Chemical structure and cytotoxic potential of ursolic and corosilic acid.
Figure 2Cytotoxic bioactive constituent from Tabernaemontana divaricata of family Apocynaceae.
Figure 3Cytotoxic constituents of Luffa cylindrica of family Araceae.
Figure 4Cytotoxic constituent from family Asterace.
Figure 5Bioactive dicinnamates from Tillandsia recurvata with cytotoxic potential.
Figure 6Cytotoxic Brazilin from Caesalpinia sappan heartwood.
Figure 7Cytotoxic components of family Lamiaceae.
Figure 8Biomarkers of family Malvaceae and mechanism of cytotoxicity.
Figure 9Cytotoxic components of Azadirachta indica.
Figure 10Cytotoxic phytoconstituents of family Moraceae.
Figure 11Bioactive cytotoxic component of Phyllanthus emblica.
Figure 12Cytotoxic compounds isolated from plants of family Zingiberaceae.
Figure 13Extrinsic apoptosis pathway showing the sites of action of cytotoxic constituents obtained from medicinal plants of Indian subcontinent.
Figure 14Intrinsic apoptosis pathway with sites of action of cytotoxic constituents obtained from medicinal plants of Indian subcontinent.